60 results
8-K
EX-3.1
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
direct, by independent legal counsel (who may, to the extent permitted by law, be regular legal counsel to the Corporation) in a written opinion
8-K
EX-3.2
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
constitutes a quorum; (iii) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion … of control (as defined below) has occurred, by independent legal counsel in a written opinion to the Board of Directors, a copy of which shall
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
14 Feb 24
Third party tender offer statement (amended)
10:35am
to reasonable advance written notice from the Representative and prior execution and delivery by an independent accounting firm of national reputation
SC TO-T/A
THRX
Theseus Pharmaceuticals Inc
7 Feb 24
Third party tender offer statement (amended)
5:15pm
’ estimate of the Disposition Proceeds is based on the co-offerors’ assessment of the CVR Products together with Theseus’ independent estimate. The CVR
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
30 Jan 24
Third party tender offer statement (amended)
8:23am
.
In connection with the Offer, none of the co-offerors engaged any independent valuation firm to conduct an analysis of the potential value of the CVR … together with Theseus’ independent estimate. The CVR Products are early-stage product candidates for which there are no plans to further advance
SC 14D9
dtnl7h0h
10 Jan 24
Tender offer solicitation
9:47am
SC TO-T
EX-99
ntu0o3w
10 Jan 24
Third party tender offer statement
8:51am
8-K
EX-2.1
h9q 85n1oqf77
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
EX-10.2
xnhg796evtliok18c
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.4
q30schey8rrp
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.1
rxref0v723imlb
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm
8-K
uhj3pw avkar8zggtkf
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:32pm
DEFA14A
39lw710lr8u4av
26 Apr 23
Additional proxy soliciting materials
9:01am
PRE 14A
xrt9ea0k6ijuan
14 Apr 23
Preliminary proxy
9:00am
S-3
EX-5.1
hyc 861ve
3 Nov 22
Shelf registration
9:06am
S-3
EX-4.5
lw12shd6rckj0av tu
3 Nov 22
Shelf registration
9:06am
S-3
EX-23.1
u2d53nms8 vp0alc
3 Nov 22
Shelf registration
9:06am